{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:41:52Z","timestamp":1794440512417,"version":"4.9.1"},"reference-count":114,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>The overriding goal of the treatment of patients is its effectiveness and safety. However, all medications currently being used also exert some adverse pharmaceutical reactions, which may be regarded as an unintended but inevitable cost of pharmacotherapy. The kidney, as the main organ that eliminates xenobiotics, is an organ especially predisposed and vulnerable to the toxic effects of drugs and their metabolites during their excretion from the body. Moreover, some drugs (e.g., aminoglycosides, cyclosporin A, cisplatin, amphotericin B, and others) have a \u201cpreferential\u201d nephrotoxicity potential, and their use is associated with an increased risk of kidney damage. Drug nephrotoxicity is, therefore, both a significant problem and a complication of pharmacotherapy. It should be noted that, currently, there is no generally recognized definition of drug-induced nephrotoxicity and no clear criteria for its diagnosis. This review briefly describes the epidemiology and diagnosis of drug-induced nephrotoxicity and characterizes its pathomechanisms, including immunological and inflammatory disturbances, altered kidney blood flow, tubulointerstitial injury, increased lithogenesis\u2013crystal nephropathy, rhabdomyolysis, and thrombotic microangiopathy. The study also lists the basic drugs with nephrotoxicity potential and provides a short overview of the preventive methods for reducing the risk of drug-related kidney damage developing.<\/jats:p>","DOI":"10.3390\/life13020325","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T03:53:18Z","timestamp":1674618798000},"page":"325","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["A Synopsis of Current Theories on Drug-Induced Nephrotoxicity"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5049-0026","authenticated-orcid":false,"given":"Lukasz","family":"Dobrek","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kalucki, S.A., Lardi, C., Garessus, J., Kfoury, A., Grabherr, S., Burnier, M., and Pruijm, M. (2020). Reference values and sex differences in absolute and relative kidney size. A Swiss autopsy study. BMC Nephrol., 21.","DOI":"10.1186\/s12882-020-01946-y"},{"key":"ref_2","unstructured":"Soriano, R.M., Penfold, D., and Leslie, S.W. (2022). StatPearls [Internet], StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1113\/jphysiol.2014.279216","article-title":"The kidney-an organ of critical importance in physiology","volume":"592","author":"Robson","year":"2014","journal-title":"J. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bcp.12086","article-title":"Renal drug metabolism in humans: The potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)","volume":"76","author":"Knights","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00498250310001638460","article-title":"Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: A review","volume":"34","author":"Korashy","year":"2004","journal-title":"Xenobiotica"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ki.2013.399","article-title":"Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport","volume":"85","author":"Yeung","year":"2014","journal-title":"Kidney Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/03602530903208561","article-title":"Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators","volume":"42","author":"Knights","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind common drug nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_9","first-page":"555576","article-title":"Drug induced kidney disease","volume":"2","author":"Siddama","year":"2017","journal-title":"Open Acc. J. Toxicol."},{"key":"ref_10","first-page":"743","article-title":"Drug-induced nephrotoxicity","volume":"78","author":"Naughton","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Awdishu, L., and Mehta, R.L. (2017). The 6R\u2019s of drug induced nephrotoxicity. BMC Nephrol., 18.","DOI":"10.1186\/s12882-017-0536-3"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.2015.115","article-title":"Phenotype standardization for drug-induced kidney disease","volume":"88","author":"Mehta","year":"2015","journal-title":"Kidney Int."},{"key":"ref_13","unstructured":"(2012). KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. Suppl., 2, 8\u2013138."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12982-015-0037-4","article-title":"Applying the Bradford Hill criteria in the 21st century: How data integration has changed causal inference in molecular epidemiology","volume":"12","author":"Fedak","year":"2015","journal-title":"Emerg. Themes Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ckj\/sfz158","article-title":"Acute kidney injury and adverse outcomes of critical illness: Correlation or causation?","volume":"13","author":"Girling","year":"2019","journal-title":"Clin. Kidney J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5414\/CP203545","article-title":"Appropriate therapeutic drug monitoring of antibiotics contributed to lower nephrotoxicity","volume":"58","author":"Alqahtani","year":"2020","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2015.12.001","article-title":"Adverse effects of drugs on the kidney","volume":"28","author":"Bartoli","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2215\/CJN.07630717","article-title":"Drug-induced acute interstitial nephritis","volume":"12","author":"Moledina","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","article-title":"Drug-induced acute interstitial nephritis","volume":"60","author":"Rossert","year":"2001","journal-title":"Kidney Int."},{"key":"ref_20","first-page":"3","article-title":"Drug-induced acute interstitial nephritis: Pathology, pathogenesis, and treatment","volume":"9","author":"Krishnan","year":"2015","journal-title":"Iran J. Kidney Dis."},{"key":"ref_21","first-page":"57","article-title":"Drug-induced renal disorders","volume":"4","author":"Assadi","year":"2015","journal-title":"J. Renal Inj. Prev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfu326","article-title":"Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury","volume":"30","author":"Praga","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2010.89","article-title":"Acute interstitial nephritis","volume":"77","author":"Praga","year":"2010","journal-title":"Kidney Int."},{"key":"ref_24","first-page":"808","article-title":"Diagnosing acute interstitial nephritis: Considerations for clinicians","volume":"12","author":"Nussbaum","year":"2019","journal-title":"Clin. Kidney J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sanchez-Alamo, B., Cases-Corona, C., and Fernandez-Juarez, G. (2022). Facing the challenge of drug-Induced acute interstitial nephritis. Nephron, Online ahead of print.","DOI":"10.1159\/000525561"},{"key":"ref_26","first-page":"1","article-title":"Drug induced tubulo-interstitial nephritis, new insight for diagnosis","volume":"31","author":"Nishio","year":"2021","journal-title":"Sysmex J. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1053\/j.ajkd.2017.05.002","article-title":"AJKD Atlas of Renal Pathology: Chronic interstitial nephritis","volume":"70","author":"Fogo","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2215\/CJN.11571017","article-title":"Nephrotoxicity and chinese herbal medicine","volume":"13","author":"Yang","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fphar.2019.00648","article-title":"Systematic overview of aristolochic acids: Nephrotoxicity, carcinogenicity, and underlying mechanisms","volume":"10","author":"Han","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s11096-018-0598-8","article-title":"Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: A cross-sectional study on potential hazards for an at risk population","volume":"40","author":"Modig","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2215\/CJN.04901107","article-title":"Analgesic nephropathy and renal replacement therapy in Australia: Trends, comorbidities and outcomes","volume":"3","author":"Chang","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_32","first-page":"84","article-title":"Analysis of drug use in patients of analgesic nephropathy","volume":"12","author":"Grover","year":"2022","journal-title":"Natl. J. Physiol. Pharm. Pharmacol."},{"key":"ref_33","first-page":"7","article-title":"Analgesic nephropathy\u2014A painful progression","volume":"9","author":"Sampathkumar","year":"2016","journal-title":"Clin. Med. Insights Urol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1590\/2175-8239-jbn-2018-0107","article-title":"Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs","volume":"41","author":"Lucas","year":"2019","journal-title":"J. Bras. Nefrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"536962","DOI":"10.1155\/2015\/536962","article-title":"NSAIDs and cardiovascular diseases: Role of reactive oxygen species","volume":"2015","author":"Ghosh","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.mnh.0000436544.86508.f1","article-title":"Intrarenal renin-angiotensin system in regulation of glomerular function","volume":"23","author":"Navar","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5049\/EBP.2008.6.1.35","article-title":"Renal effects of prostaglandins and cyclooxygenase-2 inhibitors","volume":"6","author":"Kim","year":"2008","journal-title":"Electrolyte Blood Press."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.7861\/clinmedicine.18-5-384","article-title":"Acute kidney injury and \u2018nephrotoxins\u2019: Mind your language","volume":"18","author":"Jones","year":"2018","journal-title":"Clin. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000505896","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers after acute kidney injury: Friend, foe, or acquaintance?","volume":"51","author":"Coca","year":"2020","journal-title":"Am. J. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/014107680109401005","article-title":"Nephrotoxicity in the elderly due to co-prescription of angiotensin converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs","volume":"94","author":"Adhiyaman","year":"2001","journal-title":"J. R. Soc. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/1060028016657839","article-title":"Drug class combination-associated acute kidney injury","volume":"50","author":"Rivosecchi","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1159\/000351648","article-title":"Calcineurin inhibitor nephrotoxicity: A review and perspective of the evidence","volume":"37","author":"Issa","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0897190014546836","article-title":"Aminoglycoside-induced nephrotoxicity","volume":"27","author":"Wargo","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1590\/S0102-76382006000400015","article-title":"Aminoglycoside nephrotoxicity","volume":"21","author":"Oliveira","year":"2006","journal-title":"Braz. J. Cardiovasc. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2165\/00002018-199005020-00003","article-title":"Amphotericin B nephrotoxicity","volume":"5","author":"Sabra","year":"1990","journal-title":"Drug Saf."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/joc.2000.12.6.463","article-title":"Amphotericin B-induced nephrotoxicity: A review","volume":"12","author":"Fanos","year":"2000","journal-title":"J. Chemother."},{"key":"ref_48","first-page":"562790","article-title":"Nephrotoxicity of HAART","volume":"2011","author":"Kalyesubula","year":"2011","journal-title":"AIDS Res. Treat."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ekir.2018.11.014","article-title":"Severe acute kidney injury and double tubulopathy due to dual toxicity caused by combination antiretroviral therapy","volume":"4","author":"Soto","year":"2018","journal-title":"Kidney Int. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2215\/CJN.10051012","article-title":"Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: A clinico-pathological study","volume":"8","author":"Zaidan","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejrad.2019.03.008","article-title":"Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies","volume":"116","author":"Faucon","year":"2019","journal-title":"Eur. J. Radiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1503\/cmaj.1040847","article-title":"Nephropathy induced by contrast media: Pathogenesis, risk factors and preventive strategies","volume":"172","author":"Goldenberg","year":"2005","journal-title":"CMAJ"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1523-1755.2005.00377.x","article-title":"Pathophysiology of contrast medium-induced nephropathy","volume":"68","author":"Persson","year":"2005","journal-title":"Kidney Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.356","article-title":"Bisphosphonate nephrotoxicity","volume":"74","author":"Perazella","year":"2008","journal-title":"Kidney Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1111\/bcp.14780","article-title":"Bisphosphonate nephropathy: A case series and review of the literature","volume":"87","author":"Florquin","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jbmr.2058","article-title":"Renal safety in patients treated with bisphosphonates for osteoporosis: A review","volume":"28","author":"Miller","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40265-017-0853-7","article-title":"Drug-induced kidney stones and crystalline nephropathy: Pathophysiology, prevention and treatment","volume":"78","author":"Daudon","year":"2018","journal-title":"Drugs"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.36740\/WLek202009226","article-title":"Kidney stone disease with special regard to drug-induced kidney stones\u2014A contemporary synopsis","volume":"73","author":"Dobrek","year":"2020","journal-title":"Wiad. Lek."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40272-019-00355-5","article-title":"Drug-induced urolithiasis in pediatric patients","volume":"21","author":"Sighinolfi","year":"2019","journal-title":"Paediatr. Drugs"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1016\/j.ekir.2021.09.003","article-title":"The crystalline nephropathies","volume":"6","author":"Perazella","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.mnh.0000447017.28852.52","article-title":"Acute and chronic kidney injury in nephrolithiasis","volume":"23","author":"Tang","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejim.2006.09.020","article-title":"The syndrome of rhabdomyolysis: Pathophysiology and diagnosis","volume":"18","author":"Giannoglou","year":"2007","journal-title":"Eur. J. Intern. Med."},{"key":"ref_65","first-page":"58","article-title":"Rhabdomyolysis: Pathogenesis, diagnosis, and treatment","volume":"15","author":"Torres","year":"2015","journal-title":"Ochsner J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nefroe.2018.01.003","article-title":"Adverse effects of the renal accumulation of haem proteins. Novel therapeutic approaches","volume":"38","author":"Sevillano","year":"2018","journal-title":"Nefrologia (Engl. Ed.)"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5144\/0256-4947.1998.525","article-title":"Drug-induced rhabdomyolysis","volume":"18","author":"Larbi","year":"1998","journal-title":"Ann. Saudi Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00008480-200404000-00017","article-title":"Drug-induced rhabdomyolysis","volume":"16","author":"Coco","year":"2004","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1503\/cmaj.160142","article-title":"Thrombotic microangiopathies: A general approach to diagnosis and management","volume":"189","author":"Arnold","year":"2017","journal-title":"CMAJ"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e12708","DOI":"10.1002\/rth2.12708","article-title":"Thrombotic microangiopathies: An illustrated review","volume":"6","author":"Kapoor","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ajh.23960","article-title":"Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin","volume":"90","author":"Reese","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: A systematic review of published reports","volume":"125","author":"Reese","year":"2015","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fmed.2020.00212","article-title":"An update in drug-induced thrombotic microangiopathy","volume":"7","author":"Chatzikonstantinou","year":"2020","journal-title":"Front. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5935\/0101-2800.20130052","article-title":"Acute nephrotoxicity of cisplatin: Molecular mechanisms","volume":"35","author":"Peres","year":"2013","journal-title":"J. Bras. Nefrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: A review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"8416763","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative stress: Harms and benefits for human health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3389\/fphys.2020.00694","article-title":"Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases","volume":"11","author":"Zucca","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_79","first-page":"5478708","article-title":"Oxidative stress in the pathophysiology of kidney disease: Implications for noninvasive monitoring and identification of biomarkers","volume":"2020","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5114\/ms.2022.117714","article-title":"Oxidative stress mechanisms as potential therapeutic targets in chronic kidney disease","volume":"38","author":"Dobrek","year":"2022","journal-title":"Med. Stud.\/Stud. Med."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Isaka, Y. (2018). Targeting TGF-\u03b2 signaling in kidney fibrosis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092532"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Park, C.H., and Yoo, T.-H. (2022). TGF-\u03b2 inhibitors for therapeutic management of kidney fibrosis. Pharmaceuticals, 15.","DOI":"10.3390\/ph15121485"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.17023.1","article-title":"Tumour necrosis factor signalling in health and disease","volume":"8","author":"Holbrook","year":"2019","journal-title":"F1000Research"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"van Loo, G., and Bertrand, M.J.M. (2022). Death by TNF: A road to inflammation. Nat. Rev. Immunol., Epub ahead of print.","DOI":"10.1038\/s41577-022-00792-3"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Hosohata, K. (2016). Role of oxidative stress in drug-induced kidney injury. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17111826"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.poamed.2016.10.002","article-title":"Novel biomarkers of acute kidney injury and chronic kidney disease","volume":"24","author":"Dobrek","year":"2017","journal-title":"Pol. Ann. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.33176\/AACB-18-00017","article-title":"Kidney injury biomarkers in an academic hospital setting: Where are we now?","volume":"40","author":"Ruhaak","year":"2019","journal-title":"Clin. Biochem. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-020518-114605","article-title":"Biomarkers of acute and chronic kidney disease","volume":"81","author":"Zhang","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e00283","DOI":"10.1016\/j.plabm.2022.e00283","article-title":"Advances in laboratory detection of acute kidney injury","volume":"31","author":"Reis","year":"2022","journal-title":"Pract. Lab. Med."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Mizdrak, M., Kumri\u0107, M., Kurir, T.T., and Bo\u017ei\u0107, J. (2022). Emerging biomarkers for early detection of chronic kidney disease. J. Pers. Med., 12.","DOI":"10.3390\/jpm12040548"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/FTD.0000000000000589","article-title":"Biomarkers of drug-induced kidney toxicity","volume":"41","author":"Griffin","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4062\/biomolther.2012.20.3.268","article-title":"Drug-induced nephrotoxicity and its biomarkers","volume":"20","author":"Kim","year":"2012","journal-title":"Biomol. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/toxsci\/kfy159","article-title":"Nephrotoxicity and renal pathophysiology: A contemporary perspective","volume":"164","author":"Barnett","year":"2018","journal-title":"Toxicol. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3949\/ccjm.69.4.289","article-title":"How to prevent, recognize, and treat drug-induced nephrotoxicity","volume":"69","author":"Guo","year":"2002","journal-title":"Cleve Clin. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2215\/CJN.11290821","article-title":"Drug-induced acute kidney injury","volume":"17","author":"Perazella","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","article-title":"GFR estimation: From physiology to public health","volume":"63","author":"Levey","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2215\/CJN.12791019","article-title":"Kidney disease, race, and GFR estimation","volume":"15","author":"Levey","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A Unifying approach for GFR estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5527\/wjn.v8.i1.23","article-title":"Dehydration and volume depletion: How to handle the misconceptions","volume":"8","author":"Asim","year":"2019","journal-title":"World J. Nephrol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/1735-5362.283813","article-title":"Vitamin E in the prevention of vancomycin-induced nephrotoxicity","volume":"15","author":"Soltani","year":"2020","journal-title":"Res. Pharm. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5096825","DOI":"10.1155\/2022\/5096825","article-title":"Potential protective effects of antioxidants against cyclophosphamide-induced nephrotoxicity","volume":"2022","author":"Ayza","year":"2022","journal-title":"Int. J. Nephrol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40001-022-00689-w","article-title":"Pharmacological agents for the prevention of colistin-induced nephrotoxicity","volume":"27","author":"Mirjalili","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jcb.25022","article-title":"Prevention of nephrotoxicity induced by cyclosporine A: Role of antioxidants","volume":"116","author":"Damiano","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/JEP.S265359","article-title":"Effect of kaempferol on tacrolimus-induced nephrotoxicity and calcineurin B1 expression level in animal model","volume":"12","author":"Ali","year":"2020","journal-title":"J. Exp. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1038\/sj.ki.5000372","article-title":"Contrast-induced nephropathy: Pharmacological prophylaxis","volume":"100","author":"Briguori","year":"2006","journal-title":"Kidney Int. Suppl."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/2212697X06666190701113043","article-title":"Coenzyme Q10 attenuates cisplatin-induced nephrotoxicity through counteracting oxidative stress and inflammation","volume":"6","author":"Bash","year":"2019","journal-title":"Clin. Cancer Drugs"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14740338.2020.1712357","article-title":"Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review","volume":"19","author":"Yaghoubi","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Ashkar, F., Bhullar, K.S., and Wu, J. (2022). The effect of polyphenols on kidney disease: Targeting mitochondria. Nutrients., 14.","DOI":"10.3390\/nu14153115"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Kwiatkowska, E., Doma\u0144ski, L., Dziedziejko, V., Kajdy, A., Stefa\u0144ska, K., and Kwiatkowski, S. (2021). The Mechanism of Drug Nephrotoxicity and the Methods for Preventing Kidney Damage. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116109"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"931843","DOI":"10.3389\/fphar.2022.931843","article-title":"Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice","volume":"13","author":"Simeoli","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of therapeutic drug monitoring","volume":"24","author":"Kang","year":"2009","journal-title":"Korean J. Intern. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"42","DOI":"10.18773\/austprescr.2008.025","article-title":"Therapeutic drug monitoring: Which drugs, why, when and how to do it","volume":"31","author":"Ghiculescu","year":"2008","journal-title":"Aust. Prescr."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Clarke, W. (2016). Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics, Elsevier Inc.","DOI":"10.1016\/B978-0-12-802025-8.00001-5"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/2\/325\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:14:36Z","timestamp":1760120076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/2\/325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":114,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["life13020325"],"URL":"https:\/\/doi.org\/10.3390\/life13020325","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]}}}